When to Start Hormone Therapy: The Timing Window
The timing window for menopausal hormone therapy: why age 60 and the first 10 years after menopause matter, how late starting changes risks, how long treatment lasts and what the yearly review covers.
The recommended time to start hormone therapy in menopause is defined as when symptoms begin, that is, before age 60 or within 10 years of the last period. International menopause guidelines call this the "timing window." When treatment starts within this window, benefits clearly outweigh risks, whereas after the window closes the balance of risk can change. This article explains what the timing window is, what changes when treatment starts late, how long treatment lasts and what is checked before starting. For the overall picture, see our menopause treatment page and, for safety questions, our article on whether hormone therapy is safe.
What Is the Timing Window?
The timing window (window of opportunity) describes the period in which the benefits of systemic hormone therapy (acting on the whole body; as pills, patches, gel or spray) clearly outweigh its risks. The criterion has two parts:
- Starting before age 60, or
- Starting less than 10 years after menopause (the last period).
Because symptoms (hot flashes, night sweats, sleep problems, mood swings) begin in most women during perimenopause (the transition before menopause) or the first years of menopause, the time to decide on treatment usually falls within this window.
Why Does the Window Matter?
In the first years of menopause, the inner lining of the blood vessels (endothelium) is still healthy and flexible. Estrogen therapy started in this period has been observed to slow the progression of hardening of the arteries (atherosclerosis) without increasing cardiovascular events. A randomized trial (ELITE) supports this view: estrogen started in the first 6 years of menopause slowed plaque (fatty deposits in the vessel wall) development in the neck arteries, whereas this effect was not seen when treatment started after 10 years.
Because plaques form on the vessel lining over time, the same protective effect is not expected when treatment starts late. The balance of benefit and risk therefore depends on age and time since menopause.
What Changes If Treatment Starts Late?
If starting treatment after age 60 or more than 10 years after menopause is being considered, guidelines emphasize the following:
- Heart and vessels: With estrogen taken by mouth (oral), the protective effect on vessels is lost; because of existing plaques, the risk of clotting and cardiovascular events may rise or stay unchanged.
- Stroke: Oral estrogen started after age 60 or after the 10th year of menopause is linked with an increase in stroke risk. When treatment is needed in this age group, estrogen applied through the skin (transdermal) (gel, spray, patch) is reported not to increase stroke risk.
- Dementia: Combined oral therapy (estrogen with a synthetic progestogen) started at 65 or older was found to roughly double the risk of dementia and Alzheimer's disease. In contrast, no increase in dementia risk was seen when treatment started before age 60. In women who enter surgical menopause young, a protective effect on cognitive function has been reported.
Starting late does not by itself mean "treatment cannot be given"; but personal risk assessment becomes more critical and options applied through the skin are usually preferred.
The Timing Window Is Different With Early Menopause
Loss of ovarian function before age 40 (premature ovarian insufficiency, POI) or entering menopause between 40 and 45 falls outside this framework. In these women, hormone therapy is recommended at least until the natural age of menopause (on average 51), whether or not there are symptoms, to reduce the risk of bone loss, cardiovascular disease and dementia. For details, see our article on early menopause.
How Long Does Treatment Last? Is There an Age Limit for Stopping?
Guidelines are against fixed rules such as "it must be stopped after 5 years or at age 55 or 65." There is no rigid age or duration limit. Treatment can continue as long as the benefit for symptom control and quality of life outweighs the risks.
What matters is regular re-evaluation:
- About 3 months after starting or changing the dose, a first check is done.
- After that, an assessment at least once a year is recommended: symptoms, side effects, the vaginal bleeding pattern, blood pressure, weight, mammography and whether cervical screening is up to date are reviewed.
- In women continuing beyond age 60, a switch to options applied through the skin is generally recommended.
When stopping is wanted, a gradual reduction over 3 to 6 months can be used; however, no significant difference in long-term return of symptoms has been found between stopping suddenly and tapering. After stopping, hot flashes may return in more than half of women.
What Is Assessed Before Starting?
- Detailed history: Severity of symptoms, menstrual pattern, personal and family cancer history (especially breast and uterine lining), blood pressure, diabetes, obesity, smoking and clot history.
- Examination: Blood pressure and weight, pelvic examination.
- Screening: Mammography and cervical screening being up to date. For the link with breast cancer, see our article on hormone therapy and breast cancer.
- Additional tests if needed: Assessing the thickness of the uterine lining in unexplained or irregular bleeding.
Frequently Asked Questions
I am over 60. Can I start hormone therapy?
Age alone is not a barrier, but the balance of benefit and risk changes. Your heart, stroke and clot risks are assessed; if treatment is started, options applied through the skin are usually considered. The decision is individual.
It has been more than 10 years since menopause. Will treatment work?
Treatment can still be effective for symptoms such as hot flashes; however, a protective effect on vessels is not expected and risk assessment matters more. For local symptoms such as vaginal dryness, local treatments that do not act on the whole body are assessed separately; see our article on genitourinary syndrome of menopause.
Will symptoms return when I stop hormone therapy?
In some women hot flashes may return. No clear long-term difference has been found between tapering gradually and stopping suddenly. The decision and method of stopping are planned with your doctor.
Is hormone therapy reassessed every year?
Yes. At least once a year, symptoms, side effects, blood pressure, mammography and cervical screening are reviewed, and the balance of benefit and risk is reassessed with your doctor. For natural (bioidentical) options, see our page on bioidentical hormone therapy.